Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement.
OBJECTIVE
To define the role of magnetic resonance imaging (MRI) and intraoperative electrophysiological recording in targeting the subthalamic nucleus (STN) in Parkinson's disease and to determine accuracy of electrode placement.


METHODS
We implanted 54 electrodes into the STN in 27 patients. Target planning was done by coordinate guidelines and visualising the STN on MRI and defined in relation to the mid-point of the AC-PC line. Intraoperative microelectrode recording was used. We adjusted electrode positions for placement in the centre of the STN electrical activity and verified this on postoperative MRI in 16 cases, which were fused to the preoperative images to measure actual error in electrode placement in the three axes.


RESULTS
Based on coordinate calculation and MRI localisation, the mean of the target was 11.5 mm lateral, 2.5 mm posterior and 4.1 mm inferior to the mid-point of the AC-PC line. Fifty good electrophysiological recordings of the STN (average length 4.65 mm) were achieved and target point adjusted in 90% of lead placements. The mean of the final target after electrophysiological correction was 11.7 mm lateral, 2.1 mm posterior, and 3.8 mm inferior to the mid-point. The distance from the centre of the electrode artefact to the final target used after electrophysiological recording on the fused images was 0.48 mm, 0.69 mm, and 2.9 mm in the x, y, and z axes, respectively. No postoperative MRI related complication was observed.


CONCLUSIONS
Both direct visualisation of the STN on MRI and intraoperative electrophysiological recording are important in defining the best target. Individual variations exist in the location of the STN target. Fewer tracks were required to define STN activity on the side operated first. Our current stereotactic method of electrode placement is relatively accurate.
Hamid
N A
NA
Department of Neurosurgery, Queen Elizabeth Medical Centre, University Hospital Birmingham, Birmingham, B15 2TH, UK.
Mitchell
R D
RD
Mocroft
P
P
Westby
G W M
GW
Milner
J
J
Pall
H
H
D000328:Adult; D000368:Aged; D046690:Deep Brain Stimulation / Q000379:methods*; D004566:Electrodes; D004594:Electrophysiology; D005260:Female; D006801:Humans; D007432:Intraoperative Period; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000628:therapy*; D012680:Sensitivity and Specificity; D020531:Subthalamic Nucleus / Q000473:pathology / Q000502:physiology*
N Engl J Med. 1998 Oct 15;339(16):1105-11
9770557
J Comp Neurol. 1997 Nov 3;387(4):588-630
9373015
Neurosurgery. 1999 Jan;44(1):118-25; discussion 125-6
9894972
Neurosurgery. 1999 Feb;44(2):303-13; discussion 313-4
9932883
J Neurosurg. 1999 Mar;90(3):583-90
10067936
Neurosurgery. 2000 Mar;46(3):613-22; discussion 622-4
10719858
J Neurosurg. 2000 Apr;92(4):615-25
10761650
Neurosurgery. 2000 Aug;47(2):282-92; discussion 292-4
10942001
Neuroscience. 2000;101(1):77-87
11068138
J Neurol Neurosurg Psychiatry. 2000 Dec;69(6):787-91
11080233
J Neurosurg. 2002 Feb;96(2):269-79
11838801
J Neurosurg. 2002 Aug;97(2):370-87
12186466
J Neurosurg. 2002 Sep;97(3):591-7
12296643
J Neurosurg. 2002 Nov;97(5):1152-66
12450038
J Neurosurg. 2003 Jul;99(1):71-7
12854747
J Neurosurg. 2003 Jul;99(1):89-99
12854749
Science. 1990 Sep 21;249(4975):1436-8
2402638
Rev Neurol (Paris). 1993;149(3):175-6
8235208
Neurosurgery. 1994 Oct;35(4):696-703; discussion 703-4
7808613
Lancet. 1995 Jan 14;345(8942):91-5
7815888
Stereotact Funct Neurosurg. 1994;62(1-4):76-84
7631092
Mov Disord. 1998;13 Suppl 3:111-8
9827606